Core Viewpoint - Sanai Health Group (01889.HK) has announced the sale of a 99% stake in its subsidiary, Luanan Hangyang Health Industry Co., Ltd., for approximately RMB 18.69 million, to improve cash flow and focus on core business areas [1] Group 1: Sale Agreement Details - The seller, Beijing Hangyang Health Technology Co., Ltd., a non-wholly owned subsidiary, has entered into an agreement with buyer Xue Wenfen for the sale [1] - The transaction will be settled in cash, with the target company not having commenced actual operations [1] - The original plan for the target company was to build production facilities to expand health product capacity, but this plan has been terminated due to unfavorable market conditions [1] Group 2: Financial Implications - The board believes that holding onto the target company's equity may not yield the best returns for shareholders [1] - The net proceeds from the sale, estimated at approximately RMB 18.68 million after related expenses, will be used for general working capital and other business development [1] - The completion of the sale is expected to improve the group's liquidity and strengthen its financial position, allowing it to focus on areas with stronger competitive advantages [1]
三爱健康集团(01889.HK)拟1869万元出售滦南航洋健康产业99%股权